More information: Alexandra Blackman et al, MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine ...

“Ovarian cancer is a misnomer,” Delaney explained ... “We could have generated the first mouse model to actually mimic this uterine serous carcinoma,” Delaney said.

"Ovarian cancer is a misnomer," Delaney explained ... "We could have generated the first mouse model to actually mimic this uterine serous carcinoma," Delaney said. "And we might have accidentally ...

Combination of Cancer Vaccine and T Cell Therapy Benefits ... The researchers successfully deployed CAR-T in a mouse model of ovarian ... July 21, 2023 — A preclinical study showed that ...

EAST LANSING, Mich. (WILX) - A Michigan State University researcher has developed a new model that may help scientists better ...

Fred Hutch Cancer Center researchers developing immunotherapies using ... which respond by stimulating both the innate and ...

CDK12 also plays a role in some ovarian cancers. Subscribe to Technology Networks ... engineered mouse model that parallels ...

Corcept's upcoming Q4 announcements include pivotal trial results for Relacorilant in ovarian cancer ... While Corcept's mouse model data above look quite favorable, there is always risk in ...

Prostate cancer is a quiet killer. In most men, it’s treatable. However, in some cases, it resists all known therapies and turns extremely deadly. A new discovery at Cold Spring Harbor Laboratory ...

Three monoclonal antibodies (cetuximab, bevacizumab and panitumumab) have been approved for the treatment of colorectal cancer in the USA and a large number of other monoclonal antibodies are ...

It’s being examined in a phase 1/2a study designed to enroll up to 15 patients for each of six different cohorts, spanning ...